Oct 2026· Clinical Cardiology· Vol 49· 0 citations· 36 references
Medicine
TL;DR
The early prognostic value of LGE extent suggests a critical time window for early fibrosis intervention, and the risk effect of LGE extent demonstrated time‐dependent attenuation.
Abstract
ABSTRACT Objectives To investigate the prognostic value of late gadolinium enhancement (LGE) extent for major adverse cardiovascular events (MACE) in dilated cardiomyopathy (DCM) patients and characterize the dynamic pattern of its risk effect over time. Methods We retrospectively enrolled patients who underwent Cardiac Magnetic Resonance (CMR) between 2020 and 2024, with MACE (cardiac death, heart failure re‐hospitalization, or sustained ventricular arrhythmia) as the endpoint. Patients were stratified by MACE occurrence. Schoenfeld residual testing showed borderline deviation of the proportional hazards (PH) assumption for LGE extent (LV mass percentage). Thus, a time‐dependent Cox model (Extended Cox PHs Model) with an LGE extent × follow‐up time interaction term was built to assess dynamic hazard ratio changes, and independent MACE risk factors were identified. Results Among 173 DCM patients (age 47 ± 15 years, 105 males), 46 (26.6%) experienced MACE after a mean follow‐up of 27 ± 16 months. The time‐dependent Cox model identified LGE extent (baseline HR: 1.243, 95% CI: 1.162–1.329, p < 0.001), the LGE extent × time interaction (HR: 0.993, 95% CI: 0.989–0.997, p = 0.001), and LV end‐diastolic volume index (LVEDVi; HR = 1.008, 95% CI: 1.003–1.014, p = 0.001) as independent MACE predictors. Notably, the risk effect of LGE extent demonstrated time‐dependent attenuation. Conclusion LV LGE extent and LVEDVi independently predict MACE in DCM patients. The early prognostic value of LGE extent suggests a critical time window for early fibrosis intervention.
Late gadolinium enhancement (LGE) is a robust prognostic marker in non-ischemic cardiomyopathies, yet its longitudinal evolution and clinical implications remain incompletely defined. We aimed to quantify LGE progression over time and evaluate its determinants and prognostic value in dilated cardiomyopathy (DCM)...
F. Bonanni, G. Todiere, I. Bellisario et al.· European Heart Journal· 0 citations
BACKGROUND
Non-ischemic dilated cardiomyopathy (NIDCM) represents a significant cause of heart failure and sudden cardiac death (SCD). Current risk stratification relies heavily on left ventricular ejection fraction (LVEF), which has limitations in predicting adverse outcomes. Late gadolinium enhancement (LGE) on cardi...
A. Meena, Vineeta Ojha, A. S. Malhi et al.· Indian Heart Journal· 0 citations
In this large multicenter cohort of end-stage HCM patients, the LGE granularity model integrating the LGE extent, location, and pattern provided strong and independent prognostic value beyond traditional prognostic factors.
J. Hudelo, J. Garot, S. Toupin et al.· European Heart Journal· 0 citations
Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) reflects myocardial fibrosis and has been associated with adverse outcomes in hypertrophic cardiomyopathy (HCM). We sought to measure its incremental prognostic value beyond established clinical and phenotypic variables in a large contemporary HCM...
H. Sheashaa, S. Keen, S. Shah et al.· European Heart Journal· 0 citations
In AR, an LGE extent > 2.6% predicts MACE better than LGE presence alone and non-ischemic predominant subendocardial-involved LGE is independently associated with MACE.
Bo Li, L. Dai, Yu-Jie Liu et al.· European Heart Journal-Cardi...· 0 citations
LGE findings were strongly and independently associated with death in both ILVD and DCM patients, with each successive LGE characteristic providing significant incremental prognostic value beyond traditional prognosticators, including LVEF.
Trecy Gonçalves, S. Duhamel, Solenn Toupin et al.· Journal of Cardiovascular Ma...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.